Targeting Serpin E1 will provide a promising therapeutic strategy for gastric cancer by disrupting the interaction between H. pylori, CAFs, and gastric cancer cells, which will become an attractive target for future research. This evidence concerns the gene SERPINE1 and gastric cancer.